ࡱ> TVSO 2bjbj 8Jօeօe*2> > 8< $#&//(WWW222J#L#L#L#L#L#L#$%(Xp#22222p#WW#2^WWJ#2J#::","W@f" 6##0#p"R(("("t2222222p#p#222#2222(222222222> I: . ______________________________________________________________________ YOUR LANGUAGE SHOULD BE APPROPIATE FOR THE POPULATION YOU ARE STUDYING **ĢƵSU CONSENT TO PARTICIPATE IN A RESEARCH STUDY (TITLE OF RESEARCH STUDY) (The study title should be placed at the top of all pages of the consent form). The following information describes the research study in which you are (your child is) being asked to participate. Please read the information carefully. At the end, you will be asked to sign if you agree to participate (and/or to allow your child to participate). PURPOSE OF STUDY: You are being asked to participate in a research study. The purpose of this study is to (describe the purpose of the study in general terms in lay language that will be understandable to the research subject/parent/guardian). (Optional) You are (Your child is) being asked to be in the study because: (Include only if it makes sense to tell participants why they are being approached.) PROCEDURES: (Describe the step-by-step activities [i.e., procedures] in which the subject will be involved. You may wish to number the steps for added clarity.) Describe in lay language, step-by-step, what will be required of, or done to, the research participants. Be concise. If the procedures are all to be listed in the consent form and there are multiple steps, use headers, bullets, tables, pictures when appropriate. If it is important for the participants to know prior to consenting that the study involves randomization, explain that they will be assigned by chance, like flipping a coin, to a study group. Explain the study groups. Indicate if there are specific requirements of the research participants, such as follow-up interviews or questionnaires. If appropriate, give the number of participants; if multicenter, give figures of all sites combined Questionnaires: What types of questions are being asked. Interviews: What type of questions are being asked Observation: What activities are being observed Audio/Video: Will the participant be audio or video taped. Medical Records: If medical records will be accessed, what type of information will be extracted. The length of time you are (your child is) expected to participate in the study is (estimate total duration of the subject's participation, either as a one-time activity or as a repeated activity over a period of time). RISKS AND/OR DISCOMFORTS: Describe immediate and long-term physical, psychological, and social risks/discomforts. Describe how the researchers are minimizing the risks/discomforts. If there are no known risks state this fact. We do not anticipate you (your child) will experience any personal risk or discomfort from taking part in this study. or This study may involve some risks or discomfort to participants. Risks of participation might include... (Note any discomforts participants may encounter, explaining their significance. Outline risks, physical or psychological, that could be greater than those encountered in everyday life. Describe provisions you have made to address such risks.)There may be uncommon or previously unknown risks. You should report any problems to the researcher. Questionnaires/ Interviews: You may skip any question you do not wish to answer (if applicable). Audio/Video: If you feel uncomfortable being audio/ videotaped, it can be turned off at your request (if applicable). BENEFITS: It is possible that you (your child) will benefit from this study by... (Describe potential benefits to the individual research subject. Note that compensation for participation is NOT considered a benefit.) or No benefit can be promised to you (your child) from your participation in this study. The study is expected to benefit (define the larger population, e.g., science or society) by (describe potential benefits to the larger population). ALTERNATIVES: If the study is examining an investigational treatment/intervention and the subject has other options for treatment outside the study, those alternatives must be explained. A standard alternative is to not participate in the research. CONFIDENTIALITY: (Describe the extent to which confidentiality of research records identifying the subject will be maintained. Briefly but as clearly as possible describe the key procedures for protecting the privacy and confidentiality of the individuals data, such as, How records will be secured. Who will have access to individually identifiable data (e.g. research collaborators, sponsors, etc.). Whether names or ID numbers will be used (if codes or numbers are assigned, describe how the linkage file will be secured). By signing this consent, you authorize the Investigators(s) and his/her/their staff to access your (study information) as may be necessary for purposes of this study. If the study is industry-sponsored, add- This information will also be shared with the Sponsor of this study, and persons working with the sponsor to oversee the study]. The investigators and their assistants will consider your records confidential to the extent permitted by law. The U.S Department of Health and Human Services (DHHS) may request to review and obtain copies of your records. Your records may also be reviewed for audit purposes by authorized University or other agents who will be bound by the same provisions of confidentiality. For studies having a federal Certificate of Confidentiality: Insert language provided by the federal agency that issued the certificate or ask your IRB for appropriate language. For studies that involve video or audio recording: Describe what will be done with tapes. Include plans for storage during use and what will be done after transcription, e.g., how long the tapes will be kept. Advise participants that audio and video recordings may be requested to be turned off, if that is true for the study. For studies that involve group interviews or focus groups Advise participants that they do not need to reveal their name, or that they may use a fictitious name. Advise participants that they must agree not to reveal anything they learn from group discussions or other activities. For studies that involve an interpreter: Describe how you will help ensure that the bilingual interpreter will maintain confidentiality. COSTS: There are no costs associated with your (your child's) participation in this study. or (Describe any costs to the subject for participation in the research project. (If relevant) Although injury is unlikely, if injury should occur, treatment will in most cases be available. If you (your child has) have insurance, your (your Childs) insurance, or if your (your childs) insurance company refuses to pay, you (your child) will be expected to pay. Funds to compensate for pain, expenses, lost wages and other damages caused by injury are not routinely available. or (Describe any compensation to the subject for participation in the research project). [Compensation may include cash payments or reimbursements to the subject, free services that the subject would not otherwise receive, or credit in academic courses.].) If the study places the participant at some risk of injury, include the following statement: You (your child) may be exposed to risk of injury from participation in this study. If injury occurs, treatment will in most cases be available. If you (your child) have insurance, your (your childs) insurance company may or may not pay for these costs. If you (your child) do not have insurance, or if your (your childs) insurance company refuses to pay, you (your child) will be expected to pay. Funds to compensate for pain, expenses, lost wages and other damages caused by injury are not routinely available. (For sponsored studies and other risks, please see the boiler plate language on the HSRO Website) COMPENSATION: If there will be compensation, say so. Describe payment or gift and schedule for their receipt. Address how payment will be prorated in the event the participant withdraws from the study prior to completion. Include information about any reimbursement for parking, transportation, etc. If there will not be compensation, say so. RIGHT TO DECLINE OR WITHDRAW: Your (your childs) participation in this study is voluntary. You (your child is) are free to refuse to participate in the study or withdraw your (his/her) consent at any time during the study. (If relevant) Your (Your childs) withdrawal or lack of participation will not affect the treatment you (are/ will be) receiving at (clinic). The investigator reserves the right to remove you (your child) without your (your childs) consent at such time that they feel it is in the best interest for you (your child). If you are an employee or student at ĢƵSU, your desire not to participate in this study or request to withdraw will not adversely affect your status as an employee or grades. CONTACT INFORMATION: (Principal Investigator's name) (phone number) will gladly answer any questions you may have concerning the purpose, procedures, and outcome of this project. If you have questions about your rights as a research subject you may contact Office of Research and Sponsored Programs (ORSP) 936-468-6606 or the ĢƵSU IRB at irb@sfasu.edu PARTICIPANT AGRREMENT: I have read the information in this consent form and agree (to allow my child) to participate in this study. I have had the chance to ask any questions I have about this study, and they have been answered for me. I am entitled to a copy of this form after it has been read and signed. ____________________________ __________________ Signature of Participant Date ____________________________ __________________ Signature of person obtaining consent Date     Page  PAGE 5 of  NUMPAGES 5 IJ % t u R S  X Ŵp^PBP7B7PhF\hTCJaJhF\hT6CJ]aJhF\hT5CJ\aJ#hF\hT6CJOJQJ^JaJhF\hT6CJOJQJaJ&hF\hT56CJOJQJ^JaJ#hF\hT5CJOJQJ^JaJhF\hT5CJ\aJ hF\hTCJOJQJ^JaJh%(56CJ$\]aJ$ hF\hThF\hT6; hzP56hF\hT6hF\hT6CJaJ % u e<{|1$gdT & F h1$^hgdT 1$^gdT dd[$\$gdT$a$gdTgdTX , - 0esz <Kyz{zib hF\hT hF\hT56CJ\]aJhF\hT56CJ\aJhF\hT56CJ]aJhF\hF\6hF\hT6CJ\aJhF\hT6hF\hTCJaJhF\hT5CJ\aJhF\hT6CJaJhF\hT5CJaJhF\hTCJaJhF\hT6CJ]aJ&/03Ydv/03QUb !,-./If**+ûûѯznznbhF\hTCJ\aJhF\hXZCJ\aJhF\hTh'bCJ\aJ hF\hTh'b5CJ\aJhF\hXZ5CJ\aJ hF\hThF\hT5CJaJhF\hT6hF\hT6CJ\aJhF\hTCJaJhF\hT5hF\hT5CJ\aJhF\hT6CJ]aJ&0Y0!/,,I,:  & FgdT & F1$gdT & F1$gdT & F h1$^hgdT dd[$\$gdT1$gdT+,~: 1!2!!!""<""""T#b#c#####J$Z$p$~$$$d%ҡ҄uggghF\hT6CJ\aJhF\hTh'bCJ]aJhF\hT6CJ]aJhF\hT5>*CJ\aJhF\hT5CJ\aJhF\hT56\]hF\hT56hF\hT6CJaJhF\hTCJaJhF\hT56CJaJhF\hT5CJaJhF\hT6( 2!!"<"""##d%h&0))*-2.4./1111gdT! ) p@ P !dd[$\$gdT1$gdT & FgdT & FgdTd%g%f&g&h&&&&&&`'l''''''' (3(?((/)0)>))**++++++,,,,--t-ȺȰqqfqh Z6CJ\aJhF\hT6CJ\aJhF\hTCJ\aJhF\hT6hF\hT5CJ\aJhF\hT5>*CJ\aJhF\hT56hF\hT56CJaJhF\hT6CJaJhF\hT5CJaJ hF\hThF\hT6CJ]aJhF\hTCJaJ(t-----1.2.4.H..A//// 000011J2K22222222222222˼ܩ䚎܀xtxtxtxtlahfJuhfJuCJaJhfJuCJaJh#jh#UhF\hT5OJQJ^JhF\hT5CJaJhF\hT56CJ]aJ h%(5hF\hT6CJ]aJhF\hT5>*CJ\aJ hF\hT hT5 h Z5hF\hT5hF\hT5CJ\aJhF\hT6CJ\aJ"1K2222222222222222gdT2222222222222222 hF\hTh#h?hF\h?CJaJh^CJaJmHnHujhfJuCJUaJhfJuhfJuCJaJjhfJuhfJuCJUaJ6&P1h:pT/ =!"#$% w2&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@6666_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH RR  Heading 1dd@&[$\$5CJ0KH$\aJ0DA D Default Paragraph FontRiR  Table Normal4 l4a (k (No List 6U 6 % Hyperlink >*B*phB^B \ Normal (Web)dd[$\$TR@T vBody Text Indent 2 ^ 6CJaJ6"6 Headerdd[$\$B' 1B l5Comment ReferenceCJaJ<B< l5 Comment TextCJaJ@jAB@ l5Comment Subject5\HbH l5 Balloon TextCJOJQJ^JaJ4 @r4 _bFooter  !2B2 ^ Body Textx</< ^Body Text CharCJaJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VGRU1a$N% ʣꂣKЛjVkUDRKQj/dR*SxMPsʧJ5$4vq^WCʽ D{>̳`3REB=꽻Ut Qy@֐\.X7<:+& 0h @>nƭBVqu ѡ{5kP?O&Cנ Aw0kPo۵(h[5($=CVs]mY2zw`nKDC]j%KXK 'P@$I=Y%C%gx'$!V(ekڤք'Qt!x7xbJ7 o߼W_y|nʒ;Fido/_1z/L?>o_;9:33`=—S,FĔ觑@)R8elmEv|!ո/,Ә%qh|'1:`ij.̳u'k CZ^WcK0'E8S߱sˮdΙ`K}A"NșM1I/AeހQתGF@A~eh-QR9C 5 ~d"9 0exp<^!͸~J7䒜t L䈝c\)Ic8E&]Sf~@Aw?'r3Ȱ&2@7k}̬naWJ}N1XGVh`L%Z`=`VKb*X=z%"sI<&n| .qc:?7/N<Z*`]u-]e|aѸ¾|mH{m3CԚ .ÕnAr)[;-ݑ$$`:Ʊ>NVl%kv:Ns _OuCX=mO4m's߸d|0n;pt2e}:zOrgI( 'B='8\L`"Ǚ 4F+8JI$rՑVLvVxNN";fVYx-,JfV<+k>hP!aLfh:HHX WQXt,:JU{,Z BpB)sֻڙӇiE4(=U\.O. +x"aMB[F7x"ytѫиK-zz>F>75eo5C9Z%c7ܼ%6M2ˊ 9B" N "1(IzZ~>Yr]H+9pd\4n(Kg\V$=]B,lוDA=eX)Ly5ot e㈮bW3gp : j$/g*QjZTa!e9#i5*j5ö fE`514g{7vnO(^ ,j~V9;kvv"adV݊oTAn7jah+y^@ARhW.GMuO "/e5[s󿬅`Z'WfPt~f}kA'0z|>ܙ|Uw{@՘tAm'`4T֠2j ۣhvWwA9 ZNU+Awvhv36V`^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!g theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] *J 1114X +d%t-22!"$ 12 #!,.4!8@0(  B S  ?*************** h x &&w'~'***********33333l 2&4&****************Jz$$%%0&0&1&2&''*******************J2(F'4h]Dh^`OJQJo(hHh  ^ `OJQJo(hHh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhhh^h`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhpp^p`OJQJo(hHh@ @ ^@ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHJ24h]D                Y9S?5T%( ZXZF\hKdfJu- o-^zPcJ=N/6#T^**@*@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial5. .[`)TahomaC.,{ @Calibri Light7.@Calibri;Wingdings?= *Cx Courier NewA$BCambria Math"hthth[@$M[@$M24** 3qHP ?M\2!xx  Evelyne Bital Roni Lias  Oh+'0t  0 < HT\dl Evelyne BitalNormal Roni Lias2Microsoft Office Word@@~@@~@[@$՜.+,0 hp  University of MiamiM*   TitleTtulo  !"#$%'()*+,-/0123456789:;<=>?@ABDEFGHIJLMNOPQRURoot Entry Fp@WData &1Table.)WordDocument8JSummaryInformation(CDocumentSummaryInformation8KCompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q